Attana AB is a privately held company based in Stockholm, Sweden with a wholly owned subsidiary in the United Kingdom, Attana Sensor Technologies Ltd. Attana is owned by several private investment companies as well as a large Swedish foundation.

If you wish to contact the Board please send an email to board@attana.com 

Rolf Classon (Chairman)

Mr. Classon has more than 30 years of management experience, mainly from Pharmacia and Bayer. At Pharmacia Rolf was responsible for Business Development in the USA and subsequently Pharmacia Biosystems. Rolf joined Bayer in 1991 and was Global President of Bayer Diagnostics and Chairman of the Executive Committee of Bayer Healthcare until the summer of 2004. Since then, Rolf works as an independent consultant and is a member of a number of boards of listed as well as private companies in the US and Europe, including Hill-Rom, Millipore, Enzon Pharmaceuticals, Auxilium Pharmaceuticals, Xanodyne Pharmaceuticals, PharmaNet and Bayer Healthcare.

Teodor Aastrup

Mr. Aastrup is co-founder and CEO of Attana, and holds an M.Sc. degree in Material Physics and a Ph.D. in Corrosion Science.  Teodor was previously employed at Biosensor Applications, where he was hired as a QCM specialist and appointed project manager of the sensor development of a QCM sensor for narcotics and explosives detection. Teodor’s former employments also include a financial advisory position at the Swedish EU-R&D Council and materials specialist position at Scania AB, managing chemical analysis for the entire Scania Group.

Anders Bolmdahl

Mr. Bolmdahl is the CEO of BUCHLA Gruppen AB, a privately held investment company with holdings in amongst others Hotel Tylösand, Univits and Enecto. He holds several board positions in BUCHLA Gruppen’s portfolio companies. Anders has been a board member of Attana since its foundation.

Annika Espander

Ms. Espander is Managing Partner of Catella Healthcare (since 2004). Her other commitments include: Cellartis AB, Stille AB, DuoCort AB, Acucort AB. Annika holds a B.Sc. in Chemistry, an Executive MBA in International Business Mgmt. and has performed 3 years of  academic research. Annika started her career at KabiVitrum in 1985-1986, which later became Pharmacia where she worked as project manager of clinical research from 1991–94. In 1994 Annika moved on to investment banking as a Healthcare sector Equity Analyst (Aros (1994-1996), Sector Head Enskilda (1996-2001), Head of Equity and Credit Research Handelsbanken (2001-2004)).

Erik Svedmark

Mr. Svedmark is CEO of SQS AB, which develops leading security solutions for the international bank and cash-in-transit market. Erik's previous employers include Bofors Aerotronics, Telia and Ericsson. During the past 6 years he has been Managing Director and Group CEO of Leab (Lövånger Elektronik AB), one of Sweden’s leading contract manufacturers of electronic products.

Axel Wachtmeister

Mr. Wachtmeister has worked for more than 15 years with the development of industrial companies.  An owner of an agriculture and forestry business, Axel is also a board member of several companies in the Carl Bennet Group including: Freesourcing AB, a leading partner for purchasing solutions within the construction and installation industries in the Nordic region, and Lifco AB, an industrial group with a turnover in excess of 500 million Euro, employing 2 300 people in 20 countries. Lifco consists of  six business areas: Dental Products, Machinery & Tools, Sawmill Equipment, Contract Manufacturing, Interiors for Vehicles and Environmental Technology.